Neuroprotective effects of an extract from the inflamed skin of rabbits inoculated with vaccinia virus on glutamate-induced neurotoxicity in cultured neuronal cell line
Authors: Itoh, Tatsuki1; Satou, Takao2; Nishida, Shozo3; Tsubaki, Masahiro3; Hashimoto, Shigeo4; Ito, Hiroyuki1
Source: Neurological Research, Volume 30, Number 4, May 2008 , pp. 430-434(5)
Publisher: Maney Publishing
Abstract:
Objective: Protein-free extracts from the inflamed skin of rabbits inoculated with vaccinia virus (Rosemorgen? and Neurotropin?) are widely employed to combat chronic pain and treat allergic conditions in human subjects in Japan. However, the pharmacologic mechanisms of Rosemorgen? and Neurotropin? remain unclear.Methods: In this study, we examined the effects of Rosemorgen? on L-glutamic acid (Glu)-induced cell death in N18-RE-105 neural cell line, which only possessed non-N-methyl-D-aspartate (NMDA)-type receptors.
Results: There were many large cytoplasmic cells and elongation of fivers in phosphate-buffered saline (PBS) additional group without Glu. In PBS and Glu simultaneous additional group, the survival ratio was decrease significantly compared with PBS alone group. Moreover, there were dead cells which did not have cytoplasm and aggregated nucleus. The Glu-induced cell death of N18-RE-105 cells was inhibited by both pre-treatment (24 hours before Glu treatment) and simultaneous treatment with Rosemorgen?. There were many large cytoplasmic cells and elongation of fivers in Rosemorgen? group.
Discussion: From this finding in N18-RE-105 cells, Rosemorgen? was concluded to inhibit Glu-induced cell death via non-NMDA type receptors. One of the pharmacologic mechanisms of Rosemorgen? has been clear. These results suggest that Rosemorgen? depresses allodynia and chronic pain through interaction with non-NMDA type receptors.Objective: Protein-free extracts from the inflamed skin of rabbits inoculated with vaccinia virus (Rosemorgen? and Neurotropin?) are widely employed to combat chronic pain and treat allergic conditions in human subjects in Japan. However, the pharmacologic mechanisms of Rosemorgen? and Neurotropin? remain unclear.
Methods: In this study, we examined the effects of Rosemorgen? on L-glutamic acid (Glu)-induced cell death in N18-RE-105 neural cell line, which only possessed non-N-methyl-D-aspartate (NMDA)-type receptors.
Results: There were many large cytoplasmic cells and elongation of fivers in phosphate-buffered saline (PBS) additional group without Glu. In PBS and Glu simultaneous additional group, the survival ratio was decrease significantly compared with PBS alone group. Moreover, there were dead cells which did not have cytoplasm and aggregated nucleus. The Glu-induced cell death of N18-RE-105 cells was inhibited by both pre-treatment (24 hours before Glu treatment) and simultaneous treatment with Rosemorgen?. There were many large cytoplasmic cells and elongation of fivers in Rosemorgen? group.
Discussion: From this finding in N18-RE-105 cells, Rosemorgen? was concluded to inhibit Glu-induced cell death via non-NMDA type receptors. One of the pharmacologic mechanisms of Rosemorgen? has been clear. These results suggest that Rosemorgen? depresses allodynia and chronic pain through interaction with non-NMDA type receptors.
Keywords: CHRONIC PAIN; N18-RE-105; NON-NMDA-TYPE RECEPTOR; VACCINIA VIRUS; L-GLUTAMIC ACID
Document Type: Research Article
DOI: http://dx.doi.org/10.1179/016164107X251763
Affiliations: 1: Department of Pathology, Kinki University School of Medicine, Osaka, Japan 2: Department of Pathology, Kinki University School of Medicine, Osaka, Japan; Division of Sports Medicine, Institute of Life Science, Kinki University, Osaka, Japan; Division of Hospital Pathology, Hospital of Kinki University School of Medicine, Osaka, Japan 3: Kinki University School of Pharmaceutical Sciences, Osaka, Japan 4: Department of Pathology, PL Hospital, Osaka, Japan
Publication date: 2008-05-01
- Authors wishing to cite fast track papers should give the journal name and the article DOI. This will enable reference linking via CrossRef and allow forward and backward citation tracking systems to associate the fast track citation with the final journal reference.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Virtual Maney - Stroke
- Top articles
- Health Sciences Spotlight
- ingentaconnect is not responsible for the content or availability of external websites
- In this: publication
- By this: publisher
- In this Subject: Neurology & Psychiatry
- By this author: Itoh, Tatsuki ; Satou, Takao ; Nishida, Shozo ; Tsubaki, Masahiro ; Hashimoto, Shigeo ; Ito, Hiroyuki

Shopping cart
Receive new issue alert
Get Permissions